Douglas Pagan

Douglas Pagan has over twenty-eight years of experience in finance, operations, and engineering. Douglas began their career in 1993 at Johnson & Johnson as a Senior Engineer/Marketing Research Associate. In 2000, they moved to JPMorgan Securities as an Associate, Investment Banking. In 2002, they joined Bristol-Myers Squibb as a Manager, International Treasury. In 2004, they joined Biogen Idec as a Director, Finance where they held several roles until 2008. From 2008 to 2014, they were the Chief Financial Officer at Acceleron Pharma. From 2018 to 2019, they were the Director at Ziopharm Oncology and from 2019 to 2020, they were the Chief Financial Officer at KSQ Therapeutics, Inc. Douglas is currently the Chief Financial Officer/Chief Operating Officer at Jnana Therapeutics.

Douglas Pagan attended Princeton University from 1989 to 1993, where they earned a Bachelor of Science in Engineering (BSE) in Chemical Engineering. Douglas then attended Columbia Business School from 1999 to 2001, where they earned a Master of Business Administration (MBA) in Finance and Accounting.